WOBURN, Mass.--AlphaGene, an integrated genomics company, said it has received a patent for agents used in genomic databases from the US Patent and Trademark Office. The patent covers the use of agents that implement continuous, selective database updates to proceed asynchronously with respect to the addition of new data into the database. These agents keep large and dynamic databases well annotated and up-to-date, while allowing users to keep long-running searches alive for entries meeting certain annotation criteria.
Changes in methods of annotation or amount of data in the databases do not limit users who continue using and researching the databases. The patented agents "sense" the status of the database entries while processing and updating the data and update only the pertinent criteria and annotations in the database. The remaining entries are left untouched.